Latest news from Datamonitor
September 17, 2007Research and Development, Sales and Marketing
Cell Therapeutics launches Phase III study for pixantroneCell Therapeutics has launched its phase III clinical trial, known as PIX303, of …
NICE approves MSD and Schering-Plough’s Ezetrol
September 14, 2007Sales and Marketing Inegy, NICE, cv
NICE has approved Merck Sharp & Dohme and Schering-Plough's Ezetrol, but recommended the cheapest version be used – effectively blocking …
Novartis launches Cubicin for MRSA
September 14, 2007Sales and Marketing
Novartis has launched Cubicin – its novel, first-in-class antibiotic – in the UK, in a new indication to treat the …
AstraZeneca looks to outflank cholesterol competitors
September 14, 2007Sales and Marketing
AstraZeneca is to conduct a head-to-head trial of Crestor against rival treatment Vytorin in the hugely competitive cholesterol treatment market.The …
BMS outsources safety monitoring to India
September 14, 2007Sales and Marketing India, safety
A team of 140 people based in Chennai, India, is to help Bristol-Myers Squibb monitor safety and side-effect reports from …
Fleishman-Hillard to assist UCB in its Cimzia launch
September 14, 2007Medical Communications
UCB is preparing its Crohn's disease treatment, Cimzia, for a 2008 launch in Europe.This is the first of a number …
Pfizer closes Kent manufacturing base
September 14, 2007Manufacturing and Production
Pfizer will close its Sandwich, Kent manufacturing plant over the next two years with the loss of 420 jobs.It spells …
Resolute wins first global account
September 12, 2007Medical Communications Resolute
London-based PR agency Resolute has won its first global account since setting up its New York office earlier this year.The …
Boehringer bids for oncology presence with lung cancer treatment
September 10, 2007Sales and Marketing
A novel treatment for lung cancer which could help patients who develop resistance to other drugs is being developed by …
UK stem-cell research to benefit from hybrid embryos decision
September 10, 2007Research and Development stem cell
A new ruling on the use of hybrid human-animal embryos could help UK researchers extend their lead over European rivals.The …
How can customer insight work for you?
September 10, 2007Sales and Marketing customers, insight, sales
It should be a very simple equation: if you can understand what motivates clinicians – and all the other prescribing …
Latest news from Datamonitor
September 10, 2007Research and Development, Sales and Marketing
Akela reports positive results for Fentanyl Taifun trialAkela Pharma has reported promising results from a phase IIb trial for its …
New Tsar of Tsars appointed to lead clinical engagement
September 6, 2007A leading heart surgeon has been appointed to ensure frontline doctors are engaged with health service reform and ensure their …
Sanofi manager wins Cranfield scholarship
September 6, 2007Business Services careers
A scholarship to study for an MBA at the renowned Cranfield School of Management has been won by a pharmaceutical …
Merck Serono seeks first-line use for Erbitux
September 6, 2007Sales and Marketing Erbitux
Merck Serono has seeking a broader licence for its cancer drug Erbitux in Europe to include use as a first-line …
AZ opens clinical pharmacology unit in China
September 6, 2007Research and Development China, em
AstraZeneca has opened its first ever clinical pharmacology unit in China, providing support for more trials to be carried out …
NICE says yes to asthma treatment Xolair
September 6, 2007Sales and Marketing Xolair
Xolair, a drug which helps control the most severe cases of allergic asthma, has been approved for use on the …
European challenge to restrictions on Sutent prescribing
September 6, 2007The European Commission has been asked to intervene in a row over a patient's access to kidney cancer drug Sutent, …
Generic challenger to Eprex approved
September 6, 2007Sales and Marketing
The first ever biosimilar version of blockbuster anaemia drug epoetin alfa has been approved in Europe.The drug is marketed by …
Look who’s talking now
September 3, 2007Medical Communications, Sales and Marketing blog, digi pharma, digital pharma, new media, social networking, technology
The internet loves a good scandal. From compromising celebrity videos to the latest political whisperings, whatever your interest in life, …
Latest content
FibroFind appoints Lee Borthwick as CEO
